Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin-resistant Streptococcaceae from clinical material.

R Lütticken1, G Kunstmann

  • 1Institute of Hygiene, University of Cologne, FRG.

Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2010
Same author

Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996-2002: results from a voluntary laboratory surveillance system.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2007
Same author

Periodic surveillance of nosocomial infections in a neurosurgery intensive care unit.

Infection·2005
Same author

Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2004
Same author

High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2004
Same author

Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.

Chemotherapy·2004

Vancomycin-resistant Gram-positive cocci, including Leuconostoc species and Enterococcus faecium, were identified in patient samples. Their clinical significance and implications for healthcare are discussed.

Area of Science:

  • Microbiology
  • Clinical Medicine
  • Infectious Diseases

Background:

  • Vancomycin resistance in Gram-positive bacteria poses a significant threat to public health.
  • The emergence of vancomycin-resistant strains necessitates ongoing surveillance and characterization.
  • Streptococcaceae family members are common causes of human infections.

Purpose of the Study:

  • To identify and characterize vancomycin-resistant Gram-positive cocci isolated from clinical specimens.
  • To determine the species of isolated vancomycin-resistant bacteria.
  • To discuss the clinical relevance of these findings.

Main Methods:

  • Bacterial isolation from patient samples.
  • Identification of bacterial isolates using standard microbiological techniques.

Related Experiment Videos

  • Antimicrobial susceptibility testing, focusing on vancomycin resistance.

    • Main Results:

    • Three strains of vancomycin-resistant Gram-positive cocci were successfully isolated.
    • Two isolates were identified as Leuconostoc species.
    • One isolate was identified as Enterococcus (Streptococcus) faecium.

    Conclusions:

    • The presence of vancomycin-resistant Leuconostoc species and Enterococcus faecium highlights the evolving landscape of antimicrobial resistance.
    • These findings underscore the importance of monitoring and managing vancomycin-resistant Gram-positive cocci in clinical settings.
    • Further research is needed to understand the transmission and clinical impact of these resistant strains.